Literature DB >> 11444407

Treating depression with selective serotonin reuptake inhibitors: a practical approach.

S M Sampson1.   

Abstract

Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444407     DOI: 10.4065/76.7.739

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Assessment of the Antidepressant Side Effects Occurrence in Patients Treated in Primary Care.

Authors:  Enisa Ramic; Subhija Prasko; Larisa Gavran; Emina Spahic
Journal:  Mater Sociomed       Date:  2020-06

Review 2.  Pituitary side effects of old and new drugs.

Authors:  Maria Chiara Zatelli; Maria Rosaria Ambrosio; Marta Bondanelli; Ettore Degli Uberti
Journal:  J Endocrinol Invest       Date:  2014-07-29       Impact factor: 4.256

3.  Fluoxetine ameliorates depressive symptoms by regulating lncRNA expression in the mouse hippocampus.

Authors:  Chuan-Ling Zhang; Yi-Jia Li; Shuang Lu; Ting Zhang; Rui Xiao; Huai-Rong Luo
Journal:  Zool Res       Date:  2021-01-18

4.  Psychological disturbances and quality of life in obese and infertile women and men.

Authors:  Piotr Kocełak; Jerzy Chudek; Beata Naworska; Monika Bąk-Sosnowska; Barbara Kotlarz; Monika Mazurek; Paweł Madej; Violetta Skrzypulec-Plinta; Piotr Skałba; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.